Johnny Andrew’s Post

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: DWA GmbH & Co. KG      ForteCare Indústria de Produtos Médicos        ADHE-ELS SA      Central Florida Kidney Centers, Inc.      AVERICUM      Apollo Dialysis Clinics      Orchard Hill Rehabilitation & Healthcare Center      AMSA Healthcare      Baihe Medical Technology      Pure Life Renal      Providence Hospital Inc      NEPHROLOGY AND HYPERTENSION ASSOCIATES      Abubakar Tafawa Balewa University Teaching Hospital, Bauchi      Laurel Brook Rehabilitation & Healthcare Center      Nodford International Co.,Ltd      Sacred Heart Hospital of Malolos Inc.      Dr.Bassam Medical Center      Orlando Clinical Research Center      PT Masa Lestari Husada - PT Masa Cipta Husada       Redsense Medical      Light Line Medical, Inc.      AOSS Medical Supply      Kawasumi Laboratories America      Hemotek Renal Center, Inc.      Mobile Vet      IDR - Instituto de Doenças Renais S.A.      National Medical College & Teaching Hospital      Bioteque Corporation      Roosevelt Rehabilitation & Healthcare Center        Medicare Jordan      INTERSKALA MEDIKA INDONESIA      Vital Healthcare Sdn Bhd      Divine Heart & Multispecialty Hospital      Bridgewater Center For Rehabilitation and Nursing      Dialife SA      Rumah Sakit Umum Bhakti Asih      The Hospital at Maayo      DaVita Malaysia  

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: SWS Hemodialysis Care Co.,Ltd        Hemodialysis Inc     Hemodialysis Inc.      HEMODIALYSIS CLINIC      HEMODIALYSIS SERVICES, INC.      Outset Medical, Inc.      Nipro Medical Corporation      Dialysis Clinic, Inc.      Satellite Healthcare / WellBound      Somatus      Diality      Mozarc Medical      American Nephrology Nurses Association (ANNA)      Long Island Community Hospital      Nephrology Nursing Certification Commission (NNCC)      Humacyte      Dialysis Care Center      Transonic Systems Inc.      Fresenius Medical Care      SBH Health System      Almoosa Health Group      Alio      Cara Therapeutics      Artio Medical, Inc.      NephroPlus      Dialyze Direct      Nipro Medical India      Ghalioungui Trading      Quanta Dialysis Technologies      Bellco is now part of Medtronic      Dialysis Education Services      Global Medical City جلوبال ميديكال سيتي        RenViva      HHD Home Healthcare LLC      Gada Spa     AlRazi Pharma Industries      Cormedix Inc.      PT.Enseval Putera Megatrading Tbk      Lepu Medical Technology (Beijing) Co., Ltd. 

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Q Medical Industries      Hanover & District Hospital      Physician Software Systems      SCW Medicath     Farmasol Tıbbi Ürünler San. ve Tic. A.Ş.      Renal Associates of Baton Rouge, LLC.       Northern California Nursing Academy      PT. Arianda Putra Pratama      Freedom At Home Dialysis      CEREHA S.A.      Inspira Health Group      PT. Oriontama Jaya      Vascular Surgery Associates      RenalWorks      tek-imaş Medıkal      Tianck Medical Co.,Ltd      PT Sing Aji Sentosa      SMT GROUP      Alzahra-Hospital      Austin Kidney Associates      Mobil Dialysis     Midwest Nephrology Associates      Meditechsys      Adventist Hospital Cebu      Sanxin Medtec      Hasheminejad Kidney Center      Physicians Choice Dialysis      Diaverum Hungary  North Mountain Medical and Rehabilitation Center     Nelson Environmental Technologies, Inc.      San Antonio Kidney      Haddon Renal Medical Specialsts      Dialyspa      Ayamed      Eastbrook Healthcare Center      The Medical City South Luzon         Biocompany Comércio e Serviços Ltda.   

𝐇𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐏𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @ https://lnkd.in/dcJq3Rez The report "𝐇𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐏𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 (𝐌𝐚𝐜𝐡𝐢𝐧𝐞, 𝐁𝐥𝐨𝐨𝐝𝐥𝐢𝐧𝐞, 𝐂𝐨𝐧𝐜𝐞𝐧𝐭𝐫𝐚𝐭𝐞 (𝐀𝐥𝐤𝐚𝐥𝐢𝐧𝐞), 𝐂𝐚𝐭𝐡𝐞𝐭𝐞𝐫, 𝐃𝐢𝐚𝐥𝐲𝐳𝐞𝐫, 𝐖𝐚𝐭𝐞𝐫 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭, 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬), 𝐌𝐨𝐝𝐚𝐥𝐢𝐭𝐲 (𝐂𝐀𝐏𝐃, 𝐍𝐨𝐜𝐭𝐮𝐫𝐧𝐚𝐥), 𝐔𝐬𝐞𝐫 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥, 𝐇𝐨𝐦𝐞 𝐂𝐚𝐫𝐞) - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2029", is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the POC diagnostics market. This is primarily due to the high and growing prevalence of diabetes, chronic kidney diseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐛𝐲 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in 2023, in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Dialysis Clinic, Inc. Rogosin Institute Western Nephrology Amsa Renal Care WEGO Blood Purification Business Group AMSA Healthcare NEPHROLOGY AND HYPERTENSION ASSOCIATES Light Line Medical, Inc. Physicians Choice Dialysis San Antonio Kidney Clinical Research Connections TIDES INSTITUTE OF HEALTH AND MEDICAL SCIENCE LLP Elik Dialysis self-care dialysis symposium Grupo Instituto do Rim do Paraná Clinical Renal Associates Residential Dialysis Solutions NEPHROLOGY & HYPERTENSION, PC NEPHROLOGICAL ASSOCIATES, PA AmericaNurse Staffing Agency Silver Cross Healthcare & Diagnostics Center kt-v.net Dialysis Training Institute of Excellence Dallas Kidney Specialists AVATAR India OAK PARK KIDNEY CENTER LLC Branson Nephrology Southern Oklahoma Kidney Center ADVANCED KIDNEY SPECIALISTS

𝐇𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐏𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆@ bit.ly/4c1ALpP The global #hemodialysis_and_peritoneal_dialysis_market in terms of revenue was estimated to be worth $92.0 billion in 2024 and is poised to reach $126.2 billion by 2029, growing at a CAGR of 6.5% from 2024 to 2029. Based on the #hemodialysis products and services market, the hemodialysis services segment holds the largest hemodialysis market share owing to growing number of ESRD patients and increasing utilization of hemodialysis treatment modality. Moreover, hemodialysis services are focusing on expanding their services offerings by launching and acquiring new dialysis centers across the globe. Based on end users, #homecare setting is expected to grow at a significant rate owing to growing preference of patients for home hemodialysis modality, technological advancements, and the cost-effectiveness of home dialysis treatment over incentre dialysis procedures. #NorthAmerica is expected to be the largest regional market for hemodialysis and #peritonealdialysis market during the forecast period. The presence of a well-established healthcare system, rapid increase in the availability of medical reimbursement for dialysis procedures, growing adoption of home-based dialysis modality, increasing prevalence of end-stage renal diseases across the nation, and strong geographical footprint of dialysis product manufacturers and service provider focusing on collaboration with renal care institutions are likely to support the hemodialysis and peritoneal dialysis market growth across the region. 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Fresenius Medical Care, Baxter International Inc., B. Braun Melsungen AG Vascular Systems, Asahi Kasei, DaVita Kidney Care, Nipro Medical Corporation, Diaverum, Medtronic, Rockwell Medical, Inc., Becton, Dickinson and Company, Dialife SA and Isopure Corp. #RenalCare #KidneyHealth #DialysisMarket #MedicalTechnology #HealthcareInnovation #ChronicKidneyDisease #TreatmentOptions #PatientCare #Nephrology #RenalTherapy #LifeSavingTreatment #HealthcareIndustry #MarketTrends #MedicalDevices #PatientWellness

𝐀 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐆𝐮𝐢𝐝𝐞 𝐭𝐨 𝐔.𝐒. 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐑𝐞𝐧𝐚𝐥 𝐑𝐞𝐩𝐥𝐚𝐜𝐞𝐦𝐞𝐧𝐭 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 - [𝐏𝐃𝐅 𝐆𝐮𝐢𝐝𝐞] ➡ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲: https://lnkd.in/dHM7aPAD The growth of the U.S. market can be attributed to the rising incidence of Acute Kidney Injury (AKI) and sepsis, rapid increase in the number of hospitals and urgent care centers, rising #hospital admission rate, and constant product launches by prominent market players. In addition, the COVID-19 outbreak has resulted in significant demand for continuous renal replacement therapy (CRRT) in the U.S. Owing to this, the market has witnessed regulatory support from various government authorities and a rise in financial incentives. These factors are expected to contribute to the growth of the U.S. market during the forecast period. The rising incidence of AKI is a key factor driving the demand for CRRT in the U.S. For instance, according to the National Kidney Foundation, Inc., 37 million people in the U.S., i.e., more than one in seven adults, are estimated to be affected with chronic kidney disease. Moreover, in the past several years, the incidence of AKI requiring Renal Replacement Therapy (RRT) has increased by about 10% annually. In 2022, the liquids segment dominated the U.S. market with a revenue share of over 65.6%. The liquid segment comprises dialysates, renal replacement fluids, anticoagulants, and saline. Increasing demand for CRRT in the treatment of #hemodynamically unstable patients and the growing number of manufacturers supplying dialysate and replacement fluids for RRT are among factors contributing to the segment growth. In 2022, the continuous venovenous hemodialysis (CVVHD) segment dominated the market with a volume share of over 35.0% in terms of procedure/treatment. The CVVHD treatment modality has high efficacy with low blood flows. The U.S. #continuous #renal #replacement #therapy market size was estimated at USD 736.03 million in 2022 and is expected to hit around USD 1,343.2 million by 2032, poised to reach at a notable CAGR of 6.2% during the forecast period 2023 to 2032. 𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 & 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗵𝗮𝗿𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝐁𝐚𝐱𝐭𝐞𝐫. 𝐁. 𝐁𝐫𝐚𝐮𝐧 𝐌𝐞𝐥𝐬𝐮𝐧𝐠𝐞𝐧 𝐀𝐆. 𝐅𝐫𝐞𝐬𝐞𝐧𝐢𝐮𝐬 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐚𝐫𝐞 𝐀𝐆. 𝐌𝐞𝐝𝐭𝐫𝐨𝐧𝐢𝐜. 𝐀𝐬𝐚𝐡𝐢 𝐊𝐚𝐬𝐞𝐢 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐨., 𝐋𝐭𝐝.. 𝐍𝐢𝐩𝐫𝐨 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧

Hemodialysis and Peritoneal Dialysis Market Forecast to 2029 Download Free Sample Report@ https://lnkd.in/dweh9dry The global Hemodialysis and peritoneal dialysis market growth forecasted to transform from USD 92.0 billion in 2024 to USD 126.2 billion by 2029, driven by a CAGR of 6.5%. This growth is driven by the rising prevalence of chronic kidney disease (CKD), particularly due to aging populations and increasing rates of diabetes and hypertension. Technological advancements, patient preference for home dialysis, and supportive reimbursement policies are key factors boosting market demand. However, complications linked to dialysis procedures and product recalls pose challenges. The market offers significant opportunities in emerging regions like China, India, and Brazil, where healthcare spending is increasing. Key players include Fresenius Medical Care, Baxter International, and DaVita Inc., and recent developments such as acquisitions and partnerships are enhancing market capabilities. North America is expected to maintain the largest market share due to its advanced healthcare infrastructure and growing adoption of home-based dialysis. #Hemodialysis #PeritonealDialysis #KidneyHealth #DialysisTreatment #ChronicKidneyDisease #RenalCare #Nephrology #PatientCare #DialysisOptions #HealthManagement

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Estor      Healthcare Alliance KSA      NephroCan      Puget Sound Kidney Centers      Lincolnwood Rehabilitation & Healthcare Center        Kanishk Surgical & Super Specialty Hospital      Western Nephrology    Renal Research Institute (RRI) )       Erbil International Hospital      Sunshine Factory Co., Ltd. (Mianzhu Yaolong)      Dirinco      Guangzhou MeCan Medical Limited      Amsa Renal Care      Renacon Pharma Ltd.      Pathfinder Medical      TEMAK S.A      Haidylena for Medical Industries      Avenu Medical      Goodwill Staffing & Recruitment      SIDANAH International Co. Ltd        Orange Technical College Winter Park & Avalon      Tuoren Medical         National Renal Care, LLC      Los Alamitos Hemodialysis Ctr      Acail Saúde     BIMC Hospital Nusa Dua      Merciful Hands Health Care       Alfa Laboratories S.A.L      H&S Technical Services, A Nipro Company     WEGO Blood Purification Business Group     Dreavia      Renalyx Health Systems Pvt. Ltd 

While World Kidney Day might be over, the role of our kidneys and the importance of renal therapies is still relevant. As part of our continuous efforts to improve dialysis outcomes, Mitra Industries Private Limited is proud to announce its triple-chambered bag - “Tri-Choice.”   Its near-neutral pH and lower glucose degradation products, improve efficacy of peritoneal dialysis therapy. Additionally, it offers three glucose concentrations for users to choose from, allowing life-sustaining therapy to be customised to each individual’s needs.   Announcement details can be viewed on ETHealthworld: https://lnkd.in/dq-Y-fnW   More information can be found on our website here: https://lnkd.in/dhagPVSp   #KidneyHealth #RenalTherapies #PeritonealDialysis #DialysisInnovation #MedicalTechnology #Healthcare #ContinuousImprovement #MitraIndustries #TriChoice #LowGDP #GlucoseDerivativeProducts #Dialysis #WorldKidneyDay #KidneyHealthForAll #EndStageRenalDisease #EquitableAccess #KidneyCare #Healthcare #FamilyWellbeing #GlobalHealth #PublicHealth

𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐑𝐞𝐧𝐚𝐥 𝐂𝐚𝐫𝐞: 𝐓𝐡𝐞 𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐚𝐧𝐝 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gscY6a99 The dialysis products and services market is experiencing robust growth, driven by the increasing prevalence of chronic kidney disease (CKD), advancements in dialysis technology, and the rising demand for effective renal care solutions. Dialysis plays a critical role in managing patients with end-stage renal disease (ESRD) by providing life-sustaining treatment through the removal of waste products and excess fluids from the blood. Let's explore the dynamic landscape of the dialysis products and services market to uncover the trends and opportunities propelling its expansion: Growing Prevalence of Chronic Kidney Disease (CKD): The global burden of CKD is rising due to factors such as diabetes, hypertension, and aging populations. This increase necessitates effective renal replacement therapies, including hemodialysis and peritoneal dialysis, to manage the disease and improve patient outcomes. The growing patient population is driving demand for dialysis products and services. Advancements in Dialysis Technology: Technological innovations in dialysis equipment and treatment modalities are enhancing the efficiency, safety, and patient experience of dialysis therapy. Advancements such as high-flux dialyzers, portable dialysis machines, and automated peritoneal dialysis systems are improving treatment outcomes, patient convenience, and quality of life. Rise of Home-Based Dialysis: The shift towards home-based dialysis, including home hemodialysis (HHD) and peritoneal dialysis (PD), is gaining momentum due to its benefits in patient convenience, flexibility, and reduced healthcare costs. Home dialysis empowers patients to manage their treatment schedules, improves quality of life, and reduces the need for frequent hospital visits, driving market growth. #Company Asahi Kasei Baxter International Inc. B. Braun Group Cantel Medical C. R. Bard GmbH Medtronic DaVita Kidney Care Fresenius Kabi Medcomp Nipro Medical Corporation NxStage Medical, Inc. Rockwell Medical, Inc. #Type Hemodialysis Products Peritoneal Dialysis Products In-center Dialysis Services Home Dialysis Services #Application Hospitals Clinics Home Healthcare #DialysisProducts #RenalCare #HomeDialysis #Telemedicine #PatientCentricCare #RegulatoryCompliance #MarketExpansion #HealthcareInnovation